The medication (morphine (16 mg/kg s.c.), the tested agents (gastric pentadecapeptide BPC 157 (10 pg, 10 ng and 10 g/kg i.p.), naloxone (10 mg/kg s.c.), haloperidol (1 mg/kg i.p.) or saline (5 ml/kg i.p.) was given accordingly at either 30 min, 20 min or 10 min before the first assessment (time "0"), and subsequently, the mice were assessed at 15, 30, 45, 60, 90, 120, 150 and 180 min intervals (time "+")
The single clinical trial that was initiated was canceled
the methods are sometimes used in combination with other one or more other PD treatment methods, such as deep brain stimulation, administration of levadopa, physical therapy, specialized diets, etc
That's the ceiling of what conventional care can reach
The Science Behind BPC-157 Discovered []
Safety Profile At BHRC, patient safety is paramount